Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization

Journal of Comparative Neurology

Volumn 511, Issue 2, 2008, Pages 271-285

  Papadeas, Sophia T ^a,b   Halloran, Christopher ^a   McCown, Thomas J ^a   Breese, George R ^a   Blake, Bonita L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendrites; ERK; Neonatal 6 hydroxydopamine; Prefrontal cortex; Sensitization

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; OXIDOPAMINE; SODIUM CHLORIDE; ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOACETONITRILE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; FLAVONOID; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MTAP2 PROTEIN, RAT; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL DISRUPTION; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VIVO STUDY; LIMBIC CORTEX; NERVE DEGENERATION; NEUROCHEMISTRY; NEWBORN; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION; ANIMAL; DENDRITE; DRUG EFFECT; DRUG POTENTIATION; HISTOLOGY; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMINOACETONITRILE; ANIMALS; DENDRITES; DOPAMINE AGONISTS; FLAVONOIDS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OXIDOPAMINE; PHOSPHORYLATION; PREFRONTAL CORTEX; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SYMPATHOLYTICS;

EID: 58149253269     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21835     Document Type: Article

References (77)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Alpar A, Palm K, Schierwagen A, Arendt T, Gartner U. 2003. Expression of constitutively active p21H-rasval12 in postmitotic pyramidal neurons results in increased dendritic size and complexity. J Comp Neurol 467:119-133.
3. Arendt T. 2004. Neurodegeneration and plasticity. Int J Dev Neurosci 22:507-514.
4. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD. 1998. The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1:602-609.
5. Binder LI, Frankfurter A, Rebhun LI. 1986. Differential localization of MAP-2 and tau in mammalian neurons in situ. Ann N Y Acad Sci 466:145-166.
6. Blanchart A, De Carlos JA, López-Mascaraque L. 2006. Time frame of mitral cell development in the mice olfactory bulb. J Comp Neurol 496:529-543.
7. Blum S, Moore AN, Adams F, Dash PK. 1999. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci 19:3535-3544.
8. Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA. 1984. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231:343-354.
9. Breese GR, Napier C, Mueller RA. 1985. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447-455.
10. Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL. 2005. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Brain Res Rev 48:57-73.
11. Bury SD, Jones TA. 2002. Unilateral sensorimotor cortex lesions in adult rats facilitate motor skill learning with the "unaffected" forelimb and training-induced dendritic structural plasticity in the motor cortex. J Neurosci 22:8597-8606.
12. Chang L, Jones Y, Ellisman MH, Goldstein LS, Karin M. 2003. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 4:521-533.
13. Chen Y, Ghosh A. 2005. Regulation of dendritic development by neuronal activity. J Neurobiol 64:4-10.
14. Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB. 2004. Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 271:2060-2066.
15. Criswell H, Mueller RA, Breese GR. 1989. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J Neurosci 9:125-133.
16. Criswell HE, Mueller RA, Breese GR. 1990. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Res 512:284-290.
17. Czogalla A, Sikorski AF. 2005. Spectrin and calpain: a 'target' and 'sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62:1913-1934.
18. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
19. Demyanenko GP, Tsai AY, Maness PF. 1999. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. J Neurosci 19:4907-4920.
20. Dijkhuizen PA, Ghosh A. 2004. BDNF regulates primary dendrite formation in cortical neurons via the PI3-kinase and MAP kinase signaling pathways. J Neurobiol 62:278-288.
21. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM. 1996. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. New Engl J Med 334:1568-1572.
22. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
23. Fiore RS, Bayer VE, Pelech SL, Posada J, Cooper JA, Baraban JM. 1993. p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendrites. Neuroscience 55:463-472.
24. Flores G, Alquicer G, Silva-Gomez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. 2005. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133:463-470.
25. Gabbot PL, Bacon SJ. 1996. The organisation of dendritic bundles in the prelimbic cortex (area 32) of the rat. Brain Res 730:75-86.
26. Gu Z, Jiang Q, Zhang G. 2001. Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death. Brain Res 901:79-84.
27. Haycock JW. 1989. Quantitation of tyrosine hydroxylase protein levels: spot immunolabeling with an affinity-purified antibody. Anal Biochem 181:259-266.
28. Hickmott PW, Ethell IM. 2006. Dendritic plasticity in the adult neocortex. Neuroscientist 12:16-28.
29. Holmes WR. 1989. The role of dendritic diameters in maximizing the effectiveness of synaptic inputs. Brain Res 478:127-137.
30. Holzer M, Rodel L, Seeger G, Gartner U, Narz F, Janke C, Heumann R, Arendt T. 2001. Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology. Neuroscience 105:1041-1054.
31. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. 2004. Pathways to schizophrenia: the impact of environmental factors. Neuropsychopharmacology 7(Suppl 1):S7-S13.
32. Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR. 1992. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. J Pharmacol Exp Ther 262:855-865.
33. Jones L, Fischer I, Levitt P. 1996. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb Cortex 6:431-445.
34. Jones LB, Stanwood GD, Reinoso BS, Washington RA, Wang HY, Friedman E, Levitt P. 2000. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci 20:4606-4614.
35. Kalcheva N, Albala JS, Binder LI, Shafit-Zagardo B. 1994. Localization of specific epitopes on human microtubule-associated protein 2. J Neurochem 63:2336-2341.
36. Kaplan DR, Miller FD. 2000. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391.
37. Klein RL, Hamby ME, Gong Y, Hirko AC, Wang S, Hughes JA, King MA, Meyer EM. 2002. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 176:66-74.
38. Krieger P, Kuner T, Sakmann B. 2007. Synaptic connections between layer 5b pyramidal neurons in mouse somatosensory cortex are independent of apical dendrite bundling. J Neurosci 27:11473-11482.
39. Lamprecht R, LeDoux J. 2004. Structural plasticity and memory. Nat Rev Neurosci 5:45-54.
40. Levitt P, Harvey JA, Friedman E, Smansky K, Murphy EH. 1997. New evidence for neurotransmitter influences on brain development. Trends Neurosci 20:269-274.
41. Liao J, Xu X, Wargovich MJ. 2000. Direct reprobing with anti-β-actin antibody as an internal control for Western blot analysis. Biotechniques 28:216-218.
42. Mainen ZF, Sejnowski TJ. 1996. Influence of dendritic structure on firing pattern in model neocortical neurons. Nature 382:363-366.
43. Mattson MP. 2007. Mitochondrial regulation of neuronal plasticity. Neurochem Res 32:707-715.
44. McCown TJ. 2006. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14:63-68.
45. McEachern JC, Shaw CA. 1999. The plasticity-pathology continuum: defining a role for the LTP phenomenon. J Neurosci Res 58:42-61.
46. Mikolaenko I, Rao, LM, Roberts RC, Kolb B, Jinnah HA. 2005. A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol Dis 20:479-490.
47. Miller FD, Kaplan DR. 2003. Signaling mechanisms underlying dendrite formation. Curr Opin Neurobiol 13:391-398.
48. Minger SL, Geddes JW, Holtz ML, Craddock SD, Whiteheart SW, Siman RG, Pettigrew LC. 1998. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res 810:181-199.
49. Morishima-Kawashima M, Kosik KS. 1996. The pool of map kinase associated with microtubules is small but constitutively active. Mol Biol Cell 7:893-905.
50. Moy SS, Breese GR, Eckerman DA. 1994. Altered activity patterns following neonatal 6-hydroxydopamine lesions to dopaminergic neurons: effect of SKF-38393. Brain Res 645:49-60.
51. Murphy EH, Fischer I, Friedman E, Grayson D, Jones L, Levitt P, O'Brien-Jenkins A, Wang HY, Wang XH. 1997. Cocaine administration in pregnant rabbits alters cortical structure and function in their progeny in the absence of maternal seizures. Exp Brain Res 114:433-441.
52. Papadeas ST, Blake BL, Knapp DJ, Breese GR. 2004. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement. J Neurosci 24:5863-5876.
53. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183.
54. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. New York: Academic Press.
55. Philpot BD, Lim JH, Halpain S, Brunjes PC. 1997. Experience-dependent modifications in MAP2 phosphorylation in rat olfactory bulb. J Neurosci 17:9596-9604.
56. Quinlan EM, Halpain S. 1996a. Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron 16: 357-368.
57. Quinlan EM, Halpain S. 1996b. Emergence of activity-dependent, bidirectional control of microtubule-associated protein MAP2 phosphorylation during postnatal development. J Neurosci 16:7627-7637.
58. Rau SW, Dubal DB, Böttner M, Gerhold LM, Wise PM. 2003. Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 23:11420-11426.
59. Redmond L, Kashani AH, Ghosh A. 2002. Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron 34:999-1010.
60. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH. 1995. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci U S A 92:8881-8885.
61. Robinson TE, Kolb B. 2004. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl 1):33-46.
62. Rockland KS, Ichinohe N. 2004. Some thoughts on cortical minicolumns. Exp Brain Res 158:265-277.
63. Sanchez C, Diaz-Nido J, Avila J. 2000. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 61:133-168.
64. Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, DeFranco DB. 2000. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275:12200-12206.
65. Stanwood GD, Washington RA, Shumsky JS, Levitt P. 2001. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience 106:5-14.
66. Stanwood GD, Parlaman JP, Levitt P. 2005. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. J Comp Neurol 487:270-282.
67. Sweatt JD. 2004. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311-317.
68. Vaillant AR, Zanassi P, Walsh GS, Aumont A, Alonso A, Miller FD. 2002. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron 34:985-998.
69. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J. 2000. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 20:8701-8709.
70. Van Eden CG, Uylings HBM. 1985. Cytoarchitectonic development of the prefrontal cortex of the rat. J Comp Neurol 241:253-267.
71. Vetter P, Roth A, Hausser M. 2001. Propagation of action potentials in dendrites depends on dendritic morphology. J Neurophysiol 85:926-937.
72. Visser JE, Bar PR, Jinnah HA. 2000. Lesch-Nyhan disease and the basal ganglia. Brain Res Rev 32:449-475.
73. Wang KK. 2000. Calpain and caspase: can you tell the difference? Trends Neurosci 23:20-26.
74. Wang X, Zhu C, Qiu L, Hagberg H, Sandberg M, Blomgren K. 2003. Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischema. J Neurochem 86:351-362.
75. Wedzony K, Fijal K, Mackowiak M. 2005. Alterations in the dendritic morphology of prefrontal pyramidal neurons in adult rats after blockade of NMDA receptors in the postnatal period. Brain Res 1062:166-170.
76. Wu GY, Deisseroth K, Tsien RW. 2001. Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology. Nat Neurosci 4:151-158.
77. Zilles K, Wree A. 1995. Cortex: areal and laminar structure. In: Paxinos G, editor. The rat nervous system, 2nd ed. San Diego: Academic Press. p 649-688.